Insider Trading Alert - JPM, FNFG, HUBG, GME And OPK Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Feb. 3, 2014, 88 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $108.30 to $608,047,660.00.

Highlighted Stocks Traded by Insiders:

JPMorgan Chase (JPM) - FREE Research Report

Crown James S who is Director at JPMorgan Chase bought 500,000 shares at $55.53 on Feb. 3, 2014. Following this transaction, the Director owned 18,803 shares meaning that the stake was reduced by 103.91% with the 500,000-share transaction.

The shares most recently traded at $55.08, down $0.45, or 0.81% since the insider transaction. Historical insider transactions for JPMorgan Chase go as follows:

  • 4-Week # shares sold: 316,696
  • 12-Week # shares sold: 339,196
  • 24-Week # shares sold: 361,696

The average volume for JPMorgan Chase has been 18.0 million shares per day over the past 30 days. JPMorgan Chase has a market cap of $208.1 billion and is part of the financial sector and banking industry. Shares are down 7.13% year-to-date as of the close of trading on Monday.

JPMorgan Chase & Co., a financial holding company, provides various financial services worldwide. The stock currently has a dividend yield of 2.75%. The company has a P/E ratio of 9.7. Currently there are 16 analysts that rate JPMorgan Chase a buy, 1 analyst rates it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on JPM - FREE

TheStreet Quant Ratings rates JPMorgan Chase as a buy. The company's strengths can be seen in multiple areas, such as its attractive valuation levels, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full JPMorgan Chase Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

First Niagara Financial Group (FNFG) - FREE Research Report

Signorille Julie who is Managing Director Operations at First Niagara Financial Group bought 1,250 shares at $8.51 on Feb. 3, 2014. Following this transaction, the Managing Director Operations owned 26,519 shares meaning that the stake was reduced by 4.95% with the 1,250-share transaction.

The shares most recently traded at $8.26, down $0.25, or 3.01% since the insider transaction. Historical insider transactions for First Niagara Financial Group go as follows:

  • 4-Week # shares bought: 20,788
  • 12-Week # shares bought: 20,788
  • 24-Week # shares bought: 24,954

The average volume for First Niagara Financial Group has been 3.7 million shares per day over the past 30 days. First Niagara Financial Group has a market cap of $3.1 billion and is part of the financial sector and banking industry. Shares are down 18.64% year-to-date as of the close of trading on Monday.

First Niagara Financial Group, Inc. operates as the bank holding company for First Niagara Bank, N.A. that provides retail and commercial banking, and other financial services to individuals, families, and businesses. The stock currently has a dividend yield of 3.7%. The company has a P/E ratio of 5.7. Currently there are 2 analysts that rate First Niagara Financial Group a buy, 2 analysts rate it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on FNFG - FREE

TheStreet Quant Ratings rates First Niagara Financial Group as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, attractive valuation levels, compelling growth in net income, increase in stock price during the past year and impressive record of earnings per share growth. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full First Niagara Financial Group Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Hub Group (HUBG) - FREE Research Report

Maltby Donald who is Chief Supply Chain Officer at Hub Group sold 10,000 shares at $40.72 on Feb. 3, 2014. Following this transaction, the Chief Supply Chain Officer owned 85,193 shares meaning that the stake was reduced by 10.5% with the 10,000-share transaction.

The shares most recently traded at $39.86, down $0.86, or 2.15% since the insider transaction. Historical insider transactions for Hub Group go as follows:

  • 4-Week # shares sold: 5,000
  • 12-Week # shares sold: 7,000
  • 24-Week # shares sold: 12,000

The average volume for Hub Group has been 277,300 shares per day over the past 30 days. Hub Group has a market cap of $1.5 billion and is part of the services sector and transportation industry. Shares are down 0.05% year-to-date as of the close of trading on Monday.

Hub Group, Inc., an asset-light freight transportation management company, provides intermodal, truck brokerage, and logistics services in North America. Its intermodal services include arranging for the movement of customers' freight in containers and trailers over long distances. The company has a P/E ratio of 21.6. Currently there are 2 analysts that rate Hub Group a buy, no analysts rate it a sell, and 11 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HUBG - FREE

TheStreet Quant Ratings rates Hub Group as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Hub Group Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

GameStop (GME) - FREE Research Report

Shern Stephanie M who is Director at GameStop sold 5,703 shares at $34.73 on Feb. 3, 2014. Following this transaction, the Director owned 7,871 shares meaning that the stake was reduced by 42.01% with the 5,703-share transaction.

The shares most recently traded at $33.51, down $1.22, or 3.65% since the insider transaction. Historical insider transactions for GameStop go as follows:

  • 4-Week # shares sold: 8,100
  • 12-Week # shares sold: 20,100
  • 24-Week # shares sold: 321,508

The average volume for GameStop has been 4.3 million shares per day over the past 30 days. GameStop has a market cap of $4.1 billion and is part of the services sector and retail industry. Shares are down 31.32% year-to-date as of the close of trading on Monday.

GameStop Corp. operates as a video game retailer. The stock currently has a dividend yield of 3.14%. The company has a P/E ratio of 11.2. Currently there are 10 analysts that rate GameStop a buy, 1 analyst rates it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on GME - FREE

TheStreet Quant Ratings rates GameStop as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, reasonable valuation levels, good cash flow from operations and compelling growth in net income. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full GameStop Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Opko Health (OPK) - FREE Research Report

Frost Phillip Md Et Al who is CEO & Chairman at Opko Health bought 15,000 shares at $7.92 on Feb. 3, 2014. Following this transaction, the CEO & Chairman owned 138.6 million shares meaning that the stake was reduced by 0.01% with the 15,000-share transaction.

The shares most recently traded at $7.69, down $0.23, or 2.97% since the insider transaction. Historical insider transactions for Opko Health go as follows:

  • 4-Week # shares bought: 30,000
  • 4-Week # shares sold: 46,730
  • 12-Week # shares bought: 30,000
  • 12-Week # shares sold: 46,730
  • 24-Week # shares bought: 30,000
  • 24-Week # shares sold: 46,730

The average volume for Opko Health has been 4.4 million shares per day over the past 30 days. Opko Health has a market cap of $3.2 billion and is part of the health care sector and health services industry. Shares are down 9.36% year-to-date as of the close of trading on Monday.

Opko Health, Inc., a pharmaceutical and diagnostics company, engages in the discovery, development, and commercialization of novel and proprietary technologies. It operates in two segments, Pharmaceuticals and Diagnostics. Currently there are 3 analysts that rate Opko Health a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on OPK - FREE

TheStreet Quant Ratings rates Opko Health as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share, deteriorating net income and weak operating cash flow. Get the full Opko Health Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Data for this article provided by Zacks Investment Research
null

If you liked this article you might like

Buffett Letter to Shareholders May Detail How He Intends to Spend $109 Billion

Buffett Letter to Shareholders May Detail How He Intends to Spend $109 Billion

Where's My Toaster? Banks Want Your Business

Where's My Toaster? Banks Want Your Business

Buffett's Succession Plan Adds Intrigue to Highly Anticipated Annual Letter

Buffett's Succession Plan Adds Intrigue to Highly Anticipated Annual Letter

It's Dumb to Think Amazon Will Be Able to Skirt Regulators Forever

It's Dumb to Think Amazon Will Be Able to Skirt Regulators Forever

Amazon Could Rise Another 18% From Here -- Bonus White Paper